Haplotype Labs vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionHaplotype LabsIsomorphic Labs
PricingContact-based (SaaS)Contact-based (pharma partnerships)
Target userPopulation genetics researchers, precision medicine developersLarge pharma companies
Core technologyPolygenic risk score modeling, SaaSAlphaFold-based predictive & generative AI
DeploymentWeb-based, no local installPartner-integrated, no standalone product
Latest milestoneNoneSeries B (2026), J&J collaboration (2026)

For precision medicine developers needing affordable, scalable polygenic risk analysis, Haplotype Labs offers a turnkey SaaS with 50-90% cost reduction. Isomorphic Labs, with its AlphaFold-driven Drug Design Engine and deep pharma partnerships, is the choice for large-scale drug discovery programs, but is inaccessible to individual researchers due to its partnership-only model.

Haplotype Labs
Haplotype Labs

Haplotype Labs builds SaaS and community tooling for population genetics, aiming to cut sequencing costs 50–90% and speed polygenic risk modeling.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
4 views
7.5k views
Skill Level
Advanced
Advanced
API Available
Platforms
Web
—
Categories
🧬 Drug Discovery & Life Sciences📊 Data & Analytics
🧬 Drug Discovery & Life Sciences
Features
Polygenic risk score (PRS) modeling
Disease risk prediction and detection
Population genetics analysis
Stated 50–90% reduction in sequencing costs
Elimination of bespoke software pipelines
Faster research timelines
Secure genetics data processing
Machine learning integration
Collaborative research platform
Community-driven tooling
Web-based SaaS delivery, no local install
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO

Who should pick which

  • Population genetics researcher
    Pick: Haplotype Labs

    The platform reduces sequencing costs by 50-90% and provides polygenic risk models without requiring custom software pipelines.

  • Large pharma drug discovery team
    Pick: Isomorphic Labs

    Isomorphic Labs partners with pharma giants like Novartis and J&J, leveraging AlphaFold for advanced drug design at scale.

  • Solo precision medicine startup
    Pick: Haplotype Labs

    Affordable SaaS without upfront partnership commitment, enabling early-stage R&D.

  • Late-stage pipeline requiring accelerated lead optimization
    Pick: Isomorphic Labs

    Its Drug Design Engine combines predictive and generative AI to iterate rapidly, as seen in its pharma collaborations.

  • Academic institution without pharma ties
    Pick: Haplotype Labs

    No need for partnerships; web-based interface and community-driven tooling suit academic research.

Frequently Asked Questions

Haplotype Labs vs Isomorphic Labs: which should you choose?

For precision medicine developers needing affordable, scalable polygenic risk analysis, Haplotype Labs offers a turnkey SaaS with 50-90% cost reduction. Isomorphic Labs, with its AlphaFold-driven Drug Design Engine and deep pharma partnerships, is the choice for large-scale drug discovery programs, but is inaccessible to individual researchers due to its partnership-only model.

Can I use Isomorphic Labs as an individual researcher?

No, Isomorphic Labs operates solely through deep pharma partnerships and does not offer a standalone product.

Does Haplotype Labs require coding skills?

No, it is a SaaS platform with a web-based interface that eliminates bespoke software pipelines.

Is Isomorphic Labs based on AlphaFold?

Yes, it builds on the Nobel Prize-winning AlphaFold system and extends it with predictive and generative AI models.

Which tool is better for cost reduction?

Haplotype Labs explicitly reduces sequencing costs by 50-90%, while Isomorphic Labs focuses on drug discovery ROI.

Can Haplotype Labs be used for drug discovery?

Its polygenic risk models are more suited for disease prediction and prevention, not direct drug molecule design.

What is the latest funding news for Isomorphic Labs?

It raised a $600M external investment round in March 2025 and closed a Series B in February 2026.

Does Haplotype Labs have any notable partnerships?

No recent news indicates partnerships; it is Y Combinator-backed and targets researchers directly.

Are these tools compliant with genetics data security?

Haplotype Labs emphasizes secure genetics data processing; Isomorphic Labs partners with pharma to ensure compliance.

More Haplotype Labs or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026